Factors associated with withdrawal bleeding after administration of oral dydrogesterone or medroxyprogesterone acetate in women with secondary amenorrhea?

Gynecologic and Obstetric Investigation

Volumn 42, Issue 2, 1996, Pages 113-116

  Battino, S ^a   Ben Ami, M ^a   Geslevich, Y ^a   Weiner, E ^a   Shalev, E ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

Author keywords

Progestational treatment; Secondary amenorrhea

Indexed keywords

BIPHASTON; DYDROGESTERONE; ESTRADIOL; GESTAGEN; LIPID; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MASTALGIA; OLIGOMENORRHEA; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SECONDARY AMENORRHEA; THICKNESS; TRANSVAGINAL ECHOGRAPHY;

EID: 0029844809     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291913     Document Type: Article

References (3)

1. Homberg R. Weissglas L, Goldman J: Improved treatment for anovulation on polycystic ovarian disease utilizing the effect of progesterone on the inappropriate gonadotropin release and clomiphcnc response. Hum Reprod 1988; 3:285-288.
2. Shangold MM, Tomai TP. Cook JD. Jacobs SL, Zinaman MJ. Chin SY. Simon JA: Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea. Fertil Steri; 1991;56:1040-1047.
3. Rarick LD, Shangold MM, Ahmed SW: Cervical rr., ucosc and serum estradiol as predictors of response to progestin challenge. Fertil Stcril 1991;54:353-355.